UNSPSC 51161545: Melquinast

This classification denotes an anti-asthmatic agent with the molecular formula C15H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0RO0SEU9AY, chemically known as ethyl 6-ethyl-5,6-dihydro-9-methyl-5-oxo-s-triazolo(1,5-c)quinazoline-2-carboxylate. but generally known as melquinast, which bears US NIH Compound Identifier 3045413. European Medicines Agency schedules Melquinast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08729MIG.

UNSPSC 51161545 Melquinast, a Commodity code, encompasses generic pharmaceutical products that state and local governments procure for distribution across health care facilities and public health programs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body visible in recent activity under this code, purchasing generic multi-source pharmaceuticals and over-the-counter products for participating state and local facilities. Work under the code centers on pharmaceutical manufacturing and supply arrangements, with vendors required to maintain current Good Manufacturing Practices (cGMP) certification, Drug Supply Chain Security Act (DSCSA) compliance, and FDA approval for all products. Vendors must establish contractual relationships with authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson Co., LLC) and manage chargeback systems, pricing flexibility across multiple formats (flat price, net price, WAC-minus), and comprehensive insurance coverage including commercial general liability of $5,000,000 per occurrence and network security liability of $2,000,000.

MMCAP's RFP (S1070000015802) posted January 20, 2026, with responses due March 26, 2026, seeks multiple contract awards for generic pharmaceuticals with product availability required by May 15, 2026, and contract effectiveness July 1, 2026. The solicitation spans Minnesota and Oregon, reflecting MMCAP's multi-state cooperative structure. Evaluation emphasizes price competitiveness (75 percent weight), with remaining points allocated to fixed pricing terms, administrative compliance, EDI capability, and agreement to a 3 percent administrative fee. Contract terms run two years for new vendors with optional extensions, or through June 30, 2028, for incumbents. Vendors face performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials. The RFP does not disclose specific award values or budget ranges, and no set-aside designations limiting responses to particular business classifications are identified in available documentation.